topiramate risk_factor_for dizziness
Evidence from:
primary |
all sources
Evidence (1 sources)
adverse effects that were significantly more common with topiramate than placebo were dizziness (11.5% vs. 5.3%)
confidence: 0.95
adverse effects that were significantly more common with topiramate than placebo were dizziness (11.5% vs. 5.3%)